Zeaxanthin Bioavailability – Absorption and Optimization

What Is Zeaxanthin Bioavailability?

Zeaxanthin is a naturally occurring carotenoid found in high concentrations in the macula of the eye, where it helps protect against oxidative stress and harmful blue light. Bioavailability refers to the proportion of ingested zeaxanthin that is actually absorbed into the bloodstream and made available for use by the body. The higher the bioavailability, the more effectively zeaxanthin can exert its protective health benefits.

Factors Influencing Bioavailability

The intestinal absorption of zeaxanthin depends on several factors that can be actively optimized:

Dietary Fat Content

Zeaxanthin is a fat-soluble carotenoid, meaning its absorption in the gut is strongly dependent on the concurrent intake of dietary fat. Research shows that consuming at least 3–5 g of fat per meal significantly enhances zeaxanthin absorption. It is therefore recommended to take zeaxanthin together with healthy fat sources such as olive oil, avocado, or nuts.

Food Matrix and Preparation

The food matrix – the physical structure of the food itself – plays a major role in how much zeaxanthin is released during digestion. Mechanical processing (e.g., blending or pureeing) and heat treatment (e.g., cooking or steaming) can break down cell walls and significantly improve the release and absorption of zeaxanthin. For example, cooked or processed corn and bell peppers release more zeaxanthin than their raw counterparts.

Chemical Form of Zeaxanthin

Zeaxanthin exists in two main forms: free zeaxanthin and esterified zeaxanthin (zeaxanthin diesters). Free zeaxanthin, commonly found in supplements, is absorbed directly without prior conversion, while esterified forms must first be hydrolyzed in the gut. Both forms can exhibit good bioavailability when provided in an appropriate formulation.

Interactions with Other Carotenoids

In the intestine, zeaxanthin competes with other carotenoids – particularly beta-carotene and lutein – for the same transport proteins (e.g., scavenger receptor class B type 1, SR-BI). Very high intake of a single carotenoid may inhibit the absorption of others. A balanced intake of multiple carotenoids is therefore more beneficial than the isolated high-dose supplementation of one.

Individual Factors

Age, genetic variants (e.g., polymorphisms in transporter genes), gut health, body fat percentage, and metabolic status all significantly influence individual zeaxanthin bioavailability. People with malabsorption conditions (e.g., Crohn's disease, celiac disease) may have reduced zeaxanthin absorption.

Dietary Sources Rich in Zeaxanthin

Foods with particularly high zeaxanthin content include:

• Yellow corn (one of the most concentrated sources)
• Red and orange bell peppers
• Goji berries (wolfberries)
• Dark leafy greens (e.g., kale, spinach – alongside lutein)
• Egg yolk (lower absolute content, but very high bioavailability due to natural fat content)

Egg yolk, despite its relatively low absolute zeaxanthin content, is considered one of the most bioavailable sources because the intrinsic fat content facilitates efficient intestinal absorption.

Supplementation and Bioavailability

In dietary supplements, zeaxanthin is frequently combined with lutein, often at a ratio of 5:1 (lutein:zeaxanthin), reflecting the natural ratio found in the macula. Oil-based softgel capsules generally offer higher bioavailability than hard capsules or tablets, as the carrier oil promotes micelle formation in the gut and facilitates absorption. Taking supplements with a fat-containing meal is broadly recommended.

Clinical Relevance

Zeaxanthin bioavailability is of particular clinical importance in the context of age-related macular degeneration (AMD), one of the leading causes of vision loss in older adults. Landmark research such as the AREDS2 trial (Age-Related Eye Disease Study 2) demonstrated that adequate intake of zeaxanthin and lutein can reduce the risk of AMD progression. Optimized bioavailability is a prerequisite for building and maintaining sufficient macular pigment optical density.

References

1. Bernstein PS et al. - Lutein, zeaxanthin, and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease. Progress in Retinal and Eye Research, 2016.
2. Age-Related Eye Disease Study 2 (AREDS2) Research Group - Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration. JAMA, 2013.
3. Tanumihardjo SA - Factors influencing the conversion of carotenoids to retinol: bioavailability and conversion. American Journal of Clinical Nutrition, 2002.